Research Article
MRI Images-Based Evaluation of Efficacy of Neoadjuvant Chemotherapy for Breast Cancer and Its Effect on Depression and Immune Function of Patients
Table 1
MDASI assessment of patients during neoadjuvant chemotherapy.
| Symptoms | Number of occurrences (times) | Percentage (%) | Score range (points) | Scoring (±s) |
| Pain | 198 | 93.2 | 0–10 | 3.75 ± 1.43 | Fatigue | 187 | 92.8 | 0–10 | 3.62 ± 1.57 | Vertigo and nausea | 182 | 92.1 | 0–10 | 4.07 ± 2.16 | Sadness | 175 | 90.4 | 0–10 | 4.15 ± 2.08 | Worry | 170 | 87.6 | 0–10 | 3.87 ± 1.66 | Tired | 166 | 85.7 | 0–10 | 3.35 ± 1.69 | Memory disorder | 164 | 85.1 | 0–10 | 2.82 ± 1.45 | Rapid breathing | 159 | 83.9 | 0–10 | 3.58 ± 1.22 | Dry mouth | 152 | 82.8 | 0–10 | 2.67 ± 1.72 | Sleep disturbance | 148 | 81.6 | 0–10 | 3.15 ± 2.76 | Palsy/sore and numb | 136 | 75.4 | 0–10 | 2.83 ± 2.37 |
|
|